| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| IPAG(1-(4-碘苯基)-3-(2-金刚烷基)胍) | 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine | 193527-91-2 | C17H22IN3 |
| IOTA-角叉菜 | [(2R,3S,4R,5R,6S)-6-[[(1R,3S,4R,5R,8S)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1R,3R,4R,5R,8S)-8-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate | 11114-20-8 | C24H36O25S2-2 |
| INTEPIRDINE中间体 | 3-Bromo-8-chloroquinoline | 205111-94-0 | C9H5BrClN |
| INTEPIRDINE中间体 | tert-butyl 4-[3-(phenylsulfonyl)quinolin-8-yl]piperazine-1-carboxylate | 607743-10-2 | C24H27N3O4S |
| IN1861,1,2-双(5-(三甲基锡基)噻吩-2-基)乙炔 | 1,2-bis(5-(trimethylstannyl)thiophen-2-yl)ethyne | 1610057-24-3 | C16H22S2Sn2 |
| IN1771,(4,8-双(5-(2-乙基己基)-4-氟噻吩基)苯并[1,2-B:4,5-B']二噻吩基)双(三甲基锡基) | (4,8-bis(5-(2-ethylhexyl)-4-fluorothiophene-2-yl)benzo[1,2-b:4,5-b’]dithiophene-2,6-diyl)bis(trimethylstanne) | 1514905-25-9 | C40H56F2S4Sn2 |
| IN1579,(E)-2,3-二(5-溴噻吩-2-基)丙烯腈 | (E)-2,3-bis(5-bromothiophen-2-yl)acrylonitrile | 439588-79-1 | C11H5Br2NS2 |
| IN1538,4,6-双(4-癸基噻吩基)-噻吩并[3,4-C][1,2,5]噻二唑(S) | 5,7-bis(4-decanyl-2-thienyl)thieno[3,4-b]thiadiazole | 914613-38-0 | C32H46N2S4 |
| IN1537,7-溴-4,4,9,9-四己基-4,9-二氢-S-茚并[1,2-B:5,6-B']二噻吩-2-甲醛 | 7-bromo-4,9-dihydro-4,4,9,9-tetrahexyl-s-indaceno[1,2-b:5,6-b']dithiophene-2-carbaldehyde | 1509939-05-2 | C41H57BrOS2 |
| IN1273,5,5'-二溴-3,3'-双(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩 | 5,5'-dibromo-3,3'-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-2,2'-bithiophene | 1974310-58-1 | C22H32Br2O8S2 |
| IMEGLIMIN盐酸盐 | imeglimin hydrochloride | 352211-11-1 | C6H13N5*ClH |
| IM-017(9-[(R)-2-{9'-腺嘌呤基[R)-2-丙基)]}-磷酰甲氧基丙基]-腺嘌呤) | [[(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl]phosphonic Acid Mono[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl] Ester | 1878175-77-9 | C17H23N10O4P |
| IKKε-IN-1抑制剂 | 5-[2-[(4-morpholinophenyl)amino]pyrimidin-4-yl]-2-tetrahydropyran-4-yloxy-benzonitrile | 1292310-49-6 | C26H27N5O3 |
| IKK-16,选择性IKK抑制剂 | IKK Inhibitor VII | 873225-46-8 | C28H29N5OS |
| II)二(4,4'-二吡唑基甲烷-N,N')-二(二氯铂 | 17β-<(1S)-1-Hydroxy-2-propynyl>androst-4-en-3-on | 72012-08-9 | C22H30O2 |
| IDH1突变体抑制剂(MUTANTIDH1-IN-1) | 2-(N-[2-(benzoimidazol-1-yl)ethanoyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)ethanamide | 1355326-21-4 | C30H31FN4O2 |
| ICI-199,441盐酸盐 | ICI 199441 hydrochloride | 115199-84-3 | C21H24Cl2N2O*ClH |
| ICARIIN衍生物 | 3,7-bis(2-hydroxyethyl)icaritin | 1067198-74-6 | C25H28O8 |
| IBERIOTOXIN毒素肽 | Iberiotoxin | 129203-60-7 | C179H274N50O55S7 |
| Honyucitrin;5,7-二羟基-2-[4-羟基-3,5-双(3-甲基-2-丁烯-1-基)苯基]-4H-1-苯并吡喃-4-酮 | Honyucitrin | 114542-44-8 | C25H26O5 |
| Histone Acetyltransferase抑制剂 | remodelin | 949912-58-7 | C15H14N4S |
| Hirsutenone; (4E)-1,7-双(3,4-二羟基苯基)-4-庚烯-3-酮 | hirsutenone | 41137-87-5 | C19H20O5 |
| Hexanedioicacid,polymerwith1,3-diisocyanato-2-methylbenzene,2,4-diisocyanato-1-methylbenzene,2-ethyl-2-(hydroxymethyl)-1,3-propanedioland2,2鈥?oxybis[ethanol] | 1,3-Diisocyanato-2-methylbenzene; 2,4-diisocyanato-1-methylbenzene; 2-ethyl-2-(hydroxymethyl)propane-1,3-diol; hexanedioic acid; 2-(2-hydroxyethoxy)ethanol | 34557-94-3 | C34H46N4O14 |
| Heudelotinone;(11aR)-1,10,11,11a-四氢-7-羟基-1,1,8-三甲基-2H-二苯并[a,d]环庚烯-2-酮 | heudelotinone | 133453-58-4 | C18H20O2 |
| Heratomol; 6-羟基-2H-呋喃并[2,3-h]-1-苯并吡喃-2-酮 | heratomol | 61265-07-4 | C11H6O4 |
| Heratomin;6-[(3-甲基-2-丁烯-1-基)氧基]-2H-呋喃并[2,3-h]-1-苯并吡喃-2-酮 | heratomin | 61265-06-3 | C16H14O4 |
| Hennadiol; 29-羟基羽扇豆醇 | lup-20(30)-ene-3β,29-diol | 20065-99-0 | C30H50O2 |
| Haptoglobin来源于混合人类血浆 | Haptoglobin from pooled human plasma | 9087-69-8 | C133H204Cl3F3N8O24S8 |
| HY-16997 (INCB3911) | {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile | 1334298-90-6 | C26H23F4N9O |
| HT-2 毒素 3-葡糖苷酸 | HT-2-3-glucuronic acid | 100690-35-5 | C28H40O14 |
| HT-2 毒素 | [(2R,4S,7R,9R,10R,11S)-2-(acetyloxymethyl)-10,11-dihydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-yl] 3-methylbutanoate | 26934-87-2 | C22H32O8 |
| HSP90抑制剂(VER-49009) | VER 49009 | 940289-57-6 | C19H18ClN3O4 |
| HSD抑制剂23 | N-[(E)-5-hydroxy-2-adamantyl]-2-methyl-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propanamide | 868604-75-5 | C24H33F3N4O2 |
| HPTP; 4-[4-(4-氯苯基)-3,6-二氢-1(2H)-吡啶基]-1-(4-氟苯基)-1-丁酮 | 4-(4-chlorophenyl)-1-<4-(4-fluorophenyl)-4-oxobutyl>-1,2,3,6-tetrahydopyridine | 52669-92-8 | C21H21ClFNO |
| HOVEYDA-SNAPPER去对称化反应催化剂 | (S)-N-((R)-3,3-dimethylbutan-2-yl)-3,3-dimethyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)butanamide | 913831-29-5 | C17H32N4O |
| HOP-17(21)-EN-3尾-OL | hop-17(21)-en-3-ol | 564-14-7 | C30H50O |
| HOECHST33258类似物5,BR | 2'-(naphth-2-yl)-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole | 23491-55-6 | C29H26N6 |
| HOECHST33258类似物2 | 2'-m-tolyl-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole | 23491-54-5 | C26H26N6 |
| HO-1-IN-1盐酸盐 | 1-[4-(4-bromophenyl)butyl]-1H-imidazole hydrochloride | 1092851-70-1 | C13H15BrN2*ClH |
| HM30181甲磺酸盐 | N-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1H)- isoquinolinyl)ethyl]phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4H-chromene-2-carboxamide mesylate | 849675-87-2 | CH4O3S*C38H36N6O7 |
| HIV蛋白酶抑制剂 | Ac-Leu-Val-Phe-aldehyde | 160369-84-6 | C22H33N3O4 |
| HIV-1衣壳抑制剂GS-6207 | N-((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide | 2189684-44-2 | C39H32ClF10N7O5S2 |
| HIV-1TATPROTEIN肽 | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg | 191936-91-1 | C64H118N32O14 |
| HGH片段-氧化型 | AOD-9604 | 221231-10-3 | C78H123N23O23S2 |
| HG2+汞离子探针 | rhodamine B thiospirolactone | 111883-10-4 | C28H30N2O2S |
| HFTB钠盐 | 1,1,1,3,3,3-hexafluoro-tert-butoxy sodium salt | 59857-46-4 | C4H3F6O*Na |
| HETA-盐酸盐 | 2[β-(4-hydroxyphenyl)-ethyl-aminomethyl]tetralone hydrochloride | 30007-39-7 | C19H21NO2*ClH |
| HER3抗体偶联体药物U3-1402 | deruxtecan | 1599440-13-7 | C52H56FN9O13 |
| HEDTA三钠 | trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate | 1330-54-7 | C10H15N2Na3O7 |
| HDAC抑制剂(OXAMFLATIN) | Oxamflatin Ethyl Ester | 342373-23-3 | C19H17NO4S |